LeMaitre Vascular, a leading supplier of medical instruments, is set to release its third-quarter earnings for fiscal year 2025 after the market closes on November 6, 2025. Analysts anticipate the company will report earnings of $0.57 per share alongside expected revenues of $62.18 million. The company has provided guidance indicating earnings per share (EPS) for the quarter may range between $0.540 and $0.590, while full-year guidance stands at $2.230 to $2.370 EPS.
In its most recent earnings report, released on August 5, 2025, LeMaitre Vascular exceeded expectations with an EPS of $0.60, surpassing the consensus estimate of $0.57 by $0.03. Revenue for that quarter reached $63.15 million, outperforming the forecast of $62.48 million. The company recorded a net margin of 20.08% and a return on equity of 13.67%, with quarterly revenue growth of 15.0% compared to the same period last year.
Market Performance and Analyst Insights
LeMaitre Vascular’s stock opened at $88.87 on Thursday. The company maintains a robust financial position, with a current ratio of 13.96, a quick ratio of 11.74, and a debt-to-equity ratio of 0.46. Its market capitalization stands at approximately $2.01 billion, with a price-to-earnings (P/E) ratio of 43.14 and a beta of 0.77. Over the past twelve months, the stock has fluctuated between a low of $71.42 and a high of $109.58.
Insider activity has shown notable movements recently. On August 11, 2025, Director David B. Roberts sold 10,815 shares at an average price of $92.39, totaling around $999,198. This sale reduced his holdings to 17,976 shares, valued at approximately $1.66 million. Additionally, CEO George W. LeMaitre sold 100,000 shares on August 6, 2025, earning $9.35 million from the sale. Following this transaction, he retained 1,727,003 shares, valued at about $161.49 million.
Institutional Investor Activity
Recent adjustments by institutional investors have also influenced LeMaitre Vascular’s stock performance. For instance, Federated Hermes Inc. increased its holdings by 0.4% during the second quarter, now owning 39,659 shares valued at $3.29 million. Similarly, the California State Teachers Retirement System raised its position by 1.7% to 18,721 shares worth $1.56 million.
Overall, institutional investors currently own 84.64% of LeMaitre Vascular’s stock, showcasing strong confidence in the company’s future prospects. As the earnings announcement approaches, the market will closely monitor the company’s performance and any insights shared during the call.
LeMaitre Vascular, Inc. specializes in developing, manufacturing, and marketing medical devices used in vascular surgery worldwide. Its product offerings include various catheters and services essential for vascular procedures, further strengthening its position in the medical instruments sector.
For those interested in the upcoming earnings call, details can be accessed on the company’s official website, where additional insights and updates will be provided.
